[ad_1] Updated July 25, 2018 18:53 ET Gilead Sciences Inc. GILD 1.64% Chief Executive Officer John Milligan will retire at the end of the year, a sudden departure of a pharmaceutical company …
Read More »The CEO of Gilead Sciences withdraws
[ad_1] Updated July 25, 2018 18:53 ET Gilead Sciences Inc. GILD 1.64% Chief Executive Officer John Milligan will retire at the end of the year, a sudden departure of a pharmaceutical company …
Read More »